117 related articles for article (PubMed ID: 9015390)
1. Inactivation and recovery of nitric oxide synthetic capability in cytokine-induced RAW 264.7 cells treated with "irreversible" NO synthase inhibitors.
Wolff DJ; Lubeskie A; Li C
Arch Biochem Biophys; 1997 Feb; 338(1):73-82. PubMed ID: 9015390
[TBL] [Abstract][Full Text] [Related]
2. Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells.
Cooper GR; Barr A; Wolff DJ
Arch Biochem Biophys; 1998 Sep; 357(2):195-206. PubMed ID: 9735160
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine.
Wolff DJ; Lubeskie A; Gauld DS; Neulander MJ
Eur J Pharmacol; 1998 Jun; 350(2-3):325-34. PubMed ID: 9696424
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of nitric oxide synthase by substituted aminoguanidines and aminoisothioureas.
Wolff DJ; Gauld DS; Neulander MJ; Southan G
J Pharmacol Exp Ther; 1997 Oct; 283(1):265-73. PubMed ID: 9336332
[TBL] [Abstract][Full Text] [Related]
5. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase.
Wolff DJ; Lubeskie A
Arch Biochem Biophys; 1995 Jan; 316(1):290-301. PubMed ID: 7530937
[TBL] [Abstract][Full Text] [Related]
6. Effect of nitric oxide synthase inhibitors on lipid peroxide formation in liver caused by endotoxin challenge.
Sakaguchi S; Furusawa S; Yokota K; Sasaki K; Takayanagi M; Takayanagi Y
Pharmacol Toxicol; 2000 Apr; 86(4):162-8. PubMed ID: 10815749
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nitric oxide synthase isoforms by porphyrins.
Wolff DJ; Naddelman RA; Lubeskie A; Saks DA
Arch Biochem Biophys; 1996 Sep; 333(1):27-34. PubMed ID: 8806750
[TBL] [Abstract][Full Text] [Related]
8. Arginine metabolism in keratinocytes and macrophages during nitric oxide biosynthesis: multiple modes of action of nitric oxide synthase inhibitors.
DeGeorge GL; Heck DE; Laskin JD
Biochem Pharmacol; 1997 Jul; 54(1):103-12. PubMed ID: 9296356
[TBL] [Abstract][Full Text] [Related]
9. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.
Wu CC; Chen SJ; Szabó C; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Apr; 114(8):1666-72. PubMed ID: 7541282
[TBL] [Abstract][Full Text] [Related]
10. Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes.
Zhang GL; Wang YH; Teng HL; Lin ZB
World J Gastroenterol; 2001 Jun; 7(3):331-4. PubMed ID: 11819785
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of nitric oxide synthase isoforms by diaminoguanidine and NG-amino-L-arginine.
Wolff DJ; Lubeskie A
Arch Biochem Biophys; 1996 Jan; 325(2):227-34. PubMed ID: 8561501
[TBL] [Abstract][Full Text] [Related]
12. Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability.
Albakri QA; Stuehr DJ
J Biol Chem; 1996 Mar; 271(10):5414-21. PubMed ID: 8621396
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine.
Bryk R; Wolff DJ
Biochemistry; 1998 Apr; 37(14):4844-52. PubMed ID: 9538001
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
Joly GA; Narayanan K; Griffith OW; Kilbourn RG
Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
[TBL] [Abstract][Full Text] [Related]
15. Human gingival fibroblasts produce nitric oxide in response to proinflammatory cytokines.
Daghigh F; Borghaei RC; Thornton RD; Bee JH
J Periodontol; 2002 Apr; 73(4):392-400. PubMed ID: 11990440
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-inhibitory effect of aminoguanidine on renal function in rats.
Waz WR; Van Liew JB; Feld LG
Kidney Blood Press Res; 1997; 20(4):211-7. PubMed ID: 9398025
[TBL] [Abstract][Full Text] [Related]
17. Expression of citrulline-nitric oxide cycle in lipopolysaccharide and cytokine-stimulated rat astroglioma C6 cells.
Zhang WY; Takiguchi M; Koshiyama Y; Gotoh T; Nagasaki A; Iwase K; Yamamoto K; Takeshima H; Negi A; Mori M
Brain Res; 1999 Dec; 849(1-2):78-84. PubMed ID: 10592289
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterial lipopolysaccharide and NG-monomethyl-L-arginine.
Weisz A; Cicatiello L; Esumi H
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):209-15. PubMed ID: 8645207
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide participation in the fungicidal mechanism of gamma interferon-activated murine macrophages against Paracoccidioides brasiliensis conidia.
Gonzalez A; de Gregori W; Velez D; Restrepo A; Cano LE
Infect Immun; 2000 May; 68(5):2546-52. PubMed ID: 10768942
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
